Abstract

This study investigates the relationship between metabolic syndrome, morbid obesity, and the risk of revision surgery in patients undergoing hip and knee arthroplasty. We analyzed data patients who underwent primary hip or knee. Participants were categorized based on the presence of metabolic syndrome and BMI classifications. Our findings indicate that neither metabolic syndrome nor morbid obesity significantly increased the likelihood of requiring revision surgery. Statistical analysis revealed no significant differences in revision rates among the groups. These results suggest that while metabolic syndrome and morbid obesity are associated with various health complications, they do not appear to influence surgical outcomes in terms of revision rates for hip and knee arthroplasty. These findings have important implications for clinical decision-making and patient counseling, as they indicate that these conditions should not be viewed as contraindications for arthroplasty. Further research is warranted to explore the mechanisms behind these outcomes and the long-term impacts on joint function and overall health in this patient population.